
Natera Inc (NASDAQ:NTRA) shares are trading lower by 31.2% at $37.66 after Hindenburg Research issued a short report on the stock.
Hindenburg Research stated, "Based on more than 2 dozen interviews with former Natera employees, patients and industry experts, a review of hundreds of online complaints, FOIA requests to state Medicaid offices and state Attorneys General, and the company’s financial filings, we show how Natera’s revenue growth has been fueled by deceptive sales and billing practices aimed at doctors, insurance companies and expectant mothers."